Under construction – not a live service
Sign in
Not yet taking people in ItalyNo phase

Developing a Self-Care Measurement Scale for People With Inflammatory Bowel Disease

Develops a questionnaire to measure self-care in adults with ulcerative colitis or Crohn disease.

Plain-language title generated from the registry record
Registry title: Development of the SC-IBD Self-Care Measurement Scale

Key facts

Where
Roma, ItalySee the site

Where in Italy

  • Fondazione Policlinico Universitario A. Gemelli IRCCSRoma, ItalyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Trial code
NCT07494227
Record updated
21 September 2026
Original description
This study aims to develop and validate a disease-specific self-care measurement scale for patients with Inflammatory Bowel Disease (IBD). The research follows a sequential mixed-methods design: a qualitative phase to identify key self-care concepts, followed by a quantitative phase to test the psychometric properties of the newly developed SC-IBD scale in an outpatient population.Read full original descriptionShow less

Development of a Self-Care Measurement Scale for Patients With Inflammatory Bowel Disease (IBD) and Its Application in an Outpatient Setting

This study aims to develop and validate a disease-specific self-care measurement scale for patients with Inflammatory Bowel Disease (IBD). The research follows a sequential mixed-methods design: a qualitative phase to identify key self-care concepts, followed by a quantitative phase to test the psychometric properties of the newly developed SC-IBD scale in an outpatient population.

Inclusion: Voluntary willingness to participate in the study; Diagnosis of Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) for at least 12 months; Follow-up in outpatient setting; Age 18 years or older; Ability to read and speak Italian; Ability to understand the study procedures; Signed informed consent.

Exclusion: Significant cognitive impairment (e.g., dementia) that may limit participation; Severe psychiatric disorders that may compromise participation; Severe clinical conditions preventing participation in interviews or questionnaire completion; Age younger than 18 years; Insufficient comprehension of the Italian language; Refusal to sign the informed consent form.

ClinicalTrials.gov NCT07494227